Health Dynavax Reports Comparable Immune Response in Shingles Vaccine Trial Dynavax Technologies Corporation announced that its experimental shingles vaccine has shown an immune response comparable to that of GSK’s widely used vaccine, Shingrix, in... Editorial3 hours ago